跳至主要内容
临床试验/ACTRN12615000841572
ACTRN12615000841572尚未招募未知

The effect of respiratory muscle training to strengthen the inspiratory muscles after a pleurodesis for malignant pleural effusion

Dr Luke Garske0 个研究点目标入组 36 人开始时间: 2015年8月13日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1. Malignant Pleural Effusion (defined as fluid around lung caused by cancer infiltrating the pleura): diagnosed on basis of (a) pleural fluid cytology or biopsy, or (b) a large exudative pleural effusion with no other cause identified and disseminated extra-thoracic malignancy.
  • 2. Participants have undergone a pleurodesis 3 weeks prior to study entry. Pleurodesis may be either surgical (VATS or thoracoscopy) or closed chest tube pleurodesis.
  • 3. No significant fluid re-accumulation on clinical assessment 3 weeks after a pleurodesis.

排除标准

  • Expected survival < 3 months
  • WHO performance status 3 or 4
  • Body mass index less than 19 or greater than 40
  • Hypoxia requiring long term oxygen therapy
  • Severe cardiac or pulmonary disease causing dyspnea
  • Neurologic disease which may affect respiratory muscle strength, or co-operation with testing
  • Long term steroid therapy
  • Significant chest pain which might interfere with breathing tests and training
  • Pleural tumour greater than 20 mm thickness on CT chest
  • Recent pneumothorax
  • Severe osteoporosis (t score <-3.5), or history of spontaneous rib fractures
  • Rib metastasis
  • Chest wall deformity (kyphoscoliosis)
  • Perforated ear drum or symptoms of eustachian tube insufficiency
  • Language barrier or other significant communication difficulty
  • Women who are pregnant

研究者

发起方
Dr Luke Garske

相似试验